Pharmaceuticals, Biotechnology and Life Sciences
601 Congress Street further builds on developer’s premier life science real estate portfolio in Boston/Cambridge BOSTON–(BUSINESS WIRE)–BioMed Realty, a leading…
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a biotechnology company developing innovative therapeutics directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced…
BOSTON–(BUSINESS WIRE)–CSafe Global (“CSafe” or the “Company”), a leading provider of cold chain shipping solutions to global pharmaceutical and life…
PARIS & WALTHAM, Mass.–(BUSINESS WIRE)–Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced today…
BOSTON–(BUSINESS WIRE)–Invetx, a pioneer in protein-based therapeutics for animal health, announced today that Dr. Joachim Hasenmaier has joined the company’s…
– ultraVIOLET Evaluated the Efficacy and Safety of Oteseconazole over 50 weeks – – Efficacy of Oteseconazole Compared to Fluconazole…
− Concentrated molybdenum-98 (cMo-98) enables up to four-fold increase of critical medical radioisotope Mo-99 production in U.S. – − First…
PHILADELPHIA–(BUSINESS WIRE)–SwanBio Therapeutics (SwanBio), a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, today announced that Sekar Kathiresan,…
Successful additions of ERAS-601 and ERAS-007, potential best-in-class inhibitors of SHP2 and ERK, respectively, enable “MAPK Clamp” approach to shut…